Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Twelve in the deal. Twelve, a carbon transformation company, announced raising $645 million financing. The new capital will...
Twelve’s $645 Million Financing
Alamar Biosciences’ $128 Million Series C Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Alamar Biosciences in the transaction. Alamar Biosciences announced it raised $128 million in Series C financing round. The financing...
Coro’s $75 Million Series C-2 Financing
Gunderson Dettmer represented Energy Impact Partners on the deal. Energy Impact Partners acted as the single investor in the $75 million Series C-2 financing of Coro,...
Moxion Power’s $100 Million Series B Financing
Gunderson Dettmer represented Energy Impact Partners on the deal. Energy Impact Partners announced its participation in the $100 million Series B financing of Moxion Power, a manufacturer...
Clari’s $225 Million Series F Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Clari on the deal. Clari, a revenue operations platform, announced its $225 million Series F financing led by Blackstone....
Alteryx’s $400 Million Acquisition of Trifacta
Fenwick & West advised Alteryx on the deal while Gunderson Dettmer represented Trifacta, and IndusLaw represented Infosys Limited. Alteryx (NYSE: AYX), a leading provider of self-service...
Alamar Biosciences’ $80 Million Series B Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Alamar Biosciences on the deal. Alamar Biosciences, a precision proteomics company, announced its $80 million Series B financing led...
Workday Ventures’ Investment in Clari
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Clari on the deal. Clari, the revenue operations leader, announced it has received a strategic investment from Workday...